Click for best price
AntiVEGF Market Size, Share 2024
The global Anti-VEGF market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Avastin Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-VEGF include Amgen Inc., F. Hoffmann-La Roche Ltd., Pfizer, Inc., Xbrane Biopharma AB, Allergan, Bayer AG, Regeneron Pharmaceuticals Inc. and Viatris Inc. (Mylan), etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-VEGF, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-VEGF. This report contains market size and forecasts of Anti-VEGF in global, including the following market information:
Global Anti-VEGF Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Anti-VEGF Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Anti-VEGF companies in 2023 (%)
We surveyed the Anti-VEGF manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-VEGF Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anti-VEGF Market Segment Percentages, by Type, 2023 (%)
Avastin
Lucentis
Eylea
Global Anti-VEGF Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anti-VEGF Market Segment Percentages, by Application, 2023 (%)
Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion
Age-Related Macular Degeneration
Global Anti-VEGF Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anti-VEGF Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-VEGF revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Anti-VEGF revenues share in global market, 2023 (%)
Key companies Anti-VEGF sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Anti-VEGF sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Xbrane Biopharma AB
Allergan, Bayer AG
Regeneron Pharmaceuticals Inc.
Viatris Inc. (Mylan)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-VEGF, market overview.
Chapter 2: Global Anti-VEGF market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-VEGF manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-VEGF in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-VEGF capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-VEGF Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
77 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-VEGF Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-VEGF Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-VEGF Overall Market Size
2.1 Global Anti-VEGF Market Size: 2023 VS 2030
2.2 Global Anti-VEGF Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Anti-VEGF Sales: 2019-2030
3 Company Landscape
3.1 Top Anti-VEGF Players in Global Market
3.2 Top Global Anti-VEGF Companies Ranked by Revenue
3.3 Global Anti-VEGF Revenue by Companies
3.4 Global Anti-VEGF Sales by Companies
3.5 Global Anti-VEGF Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Anti-VEGF Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Anti-VEGF Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-VEGF Players in Global Market
3.8.1 List of Global Tier 1 Anti-VEGF Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-VEGF Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-VEGF Market Size Markets, 2023 & 2030
4.1.2 Avastin
4.1.3 Lucentis
4.1.4 Eylea
4.2 By Type - Global Anti-VEGF Revenue & Forecasts
4.2.1 By Type - Global Anti-VEGF Revenue, 2019-2024
4.2.2 By Type - Global Anti-VEGF Revenue, 2025-2030
4.2.3 By Type - Global Anti-VEGF Revenue Market Share, 2019-2030
4.3 By Type - Global Anti-VEGF Sales & Forecasts
4.3.1 By Type - Global Anti-VEGF Sales, 2019-2024
4.3.2 By Type - Global Anti-VEGF Sales, 2025-2030
4.3.3 By Type - Global Anti-VEGF Sales Market Share, 2019-2030
4.4 By Type - Global Anti-VEGF Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-VEGF Market Size, 2023 & 2030
5.1.2 Macular Edema
5.1.3 Diabetic Retinopathy
5.1.4 Retinal Vein Occlusion
5.1.5 Age-Related Macular Degeneration
5.2 By Application - Global Anti-VEGF Revenue & Forecasts
5.2.1 By Application - Global Anti-VEGF Revenue, 2019-2024
5.2.2 By Application - Global Anti-VEGF Revenue, 2025-2030
5.2.3 By Application - Global Anti-VEGF Revenue Market Share, 2019-2030
5.3 By Application - Global Anti-VEGF Sales & Forecasts
5.3.1 By Application - Global Anti-VEGF Sales, 2019-2024
5.3.2 By Application - Global Anti-VEGF Sales, 2025-2030
5.3.3 By Application - Global Anti-VEGF Sales Market Share, 2019-2030
5.4 By Application - Global Anti-VEGF Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Anti-VEGF Market Size, 2023 & 2030
6.2 By Region - Global Anti-VEGF Revenue & Forecasts
6.2.1 By Region - Global Anti-VEGF Revenue, 2019-2024
6.2.2 By Region - Global Anti-VEGF Revenue, 2025-2030
6.2.3 By Region - Global Anti-VEGF Revenue Market Share, 2019-2030
6.3 By Region - Global Anti-VEGF Sales & Forecasts
6.3.1 By Region - Global Anti-VEGF Sales, 2019-2024
6.3.2 By Region - Global Anti-VEGF Sales, 2025-2030
6.3.3 By Region - Global Anti-VEGF Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Anti-VEGF Revenue, 2019-2030
6.4.2 By Country - North America Anti-VEGF Sales, 2019-2030
6.4.3 US Anti-VEGF Market Size, 2019-2030
6.4.4 Canada Anti-VEGF Market Size, 2019-2030
6.4.5 Mexico Anti-VEGF Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Anti-VEGF Revenue, 2019-2030
6.5.2 By Country - Europe Anti-VEGF Sales, 2019-2030
6.5.3 Germany Anti-VEGF Market Size, 2019-2030
6.5.4 France Anti-VEGF Market Size, 2019-2030
6.5.5 U.K. Anti-VEGF Market Size, 2019-2030
6.5.6 Italy Anti-VEGF Market Size, 2019-2030
6.5.7 Russia Anti-VEGF Market Size, 2019-2030
6.5.8 Nordic Countries Anti-VEGF Market Size, 2019-2030
6.5.9 Benelux Anti-VEGF Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Anti-VEGF Revenue, 2019-2030
6.6.2 By Region - Asia Anti-VEGF Sales, 2019-2030
6.6.3 China Anti-VEGF Market Size, 2019-2030
6.6.4 Japan Anti-VEGF Market Size, 2019-2030
6.6.5 South Korea Anti-VEGF Market Size, 2019-2030
6.6.6 Southeast Asia Anti-VEGF Market Size, 2019-2030
6.6.7 India Anti-VEGF Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Anti-VEGF Revenue, 2019-2030
6.7.2 By Country - South America Anti-VEGF Sales, 2019-2030
6.7.3 Brazil Anti-VEGF Market Size, 2019-2030
6.7.4 Argentina Anti-VEGF Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-VEGF Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Anti-VEGF Sales, 2019-2030
6.8.3 Turkey Anti-VEGF Market Size, 2019-2030
6.8.4 Israel Anti-VEGF Market Size, 2019-2030
6.8.5 Saudi Arabia Anti-VEGF Market Size, 2019-2030
6.8.6 UAE Anti-VEGF Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Anti-VEGF Major Product Offerings
7.1.4 Amgen Inc. Anti-VEGF Sales and Revenue in Global (2019-2024)
7.1.5 Amgen Inc. Key News & Latest Developments
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 F. Hoffmann-La Roche Ltd. Company Summary
7.2.2 F. Hoffmann-La Roche Ltd. Business Overview
7.2.3 F. Hoffmann-La Roche Ltd. Anti-VEGF Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd. Anti-VEGF Sales and Revenue in Global (2019-2024)
7.2.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.3 Pfizer, Inc.
7.3.1 Pfizer, Inc. Company Summary
7.3.2 Pfizer, Inc. Business Overview
7.3.3 Pfizer, Inc. Anti-VEGF Major Product Offerings
7.3.4 Pfizer, Inc. Anti-VEGF Sales and Revenue in Global (2019-2024)
7.3.5 Pfizer, Inc. Key News & Latest Developments
7.4 Xbrane Biopharma AB
7.4.1 Xbrane Biopharma AB Company Summary
7.4.2 Xbrane Biopharma AB Business Overview
7.4.3 Xbrane Biopharma AB Anti-VEGF Major Product Offerings
7.4.4 Xbrane Biopharma AB Anti-VEGF Sales and Revenue in Global (2019-2024)
7.4.5 Xbrane Biopharma AB Key News & Latest Developments
7.5 Allergan, Bayer AG
7.5.1 Allergan, Bayer AG Company Summary
7.5.2 Allergan, Bayer AG Business Overview
7.5.3 Allergan, Bayer AG Anti-VEGF Major Product Offerings
7.5.4 Allergan, Bayer AG Anti-VEGF Sales and Revenue in Global (2019-2024)
7.5.5 Allergan, Bayer AG Key News & Latest Developments
7.6 Regeneron Pharmaceuticals Inc.
7.6.1 Regeneron Pharmaceuticals Inc. Company Summary
7.6.2 Regeneron Pharmaceuticals Inc. Business Overview
7.6.3 Regeneron Pharmaceuticals Inc. Anti-VEGF Major Product Offerings
7.6.4 Regeneron Pharmaceuticals Inc. Anti-VEGF Sales and Revenue in Global (2019-2024)
7.6.5 Regeneron Pharmaceuticals Inc. Key News & Latest Developments
7.7 Viatris Inc. (Mylan)
7.7.1 Viatris Inc. (Mylan) Company Summary
7.7.2 Viatris Inc. (Mylan) Business Overview
7.7.3 Viatris Inc. (Mylan) Anti-VEGF Major Product Offerings
7.7.4 Viatris Inc. (Mylan) Anti-VEGF Sales and Revenue in Global (2019-2024)
7.7.5 Viatris Inc. (Mylan) Key News & Latest Developments
8 Global Anti-VEGF Production Capacity, Analysis
8.1 Global Anti-VEGF Production Capacity, 2019-2030
8.2 Anti-VEGF Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-VEGF Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-VEGF Supply Chain Analysis
10.1 Anti-VEGF Industry Value Chain
10.2 Anti-VEGF Upstream Market
10.3 Anti-VEGF Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-VEGF Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-VEGF in Global Market
Table 2. Top Anti-VEGF Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Anti-VEGF Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Anti-VEGF Revenue Share by Companies, 2019-2024
Table 5. Global Anti-VEGF Sales by Companies, (K Units), 2019-2024
Table 6. Global Anti-VEGF Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Anti-VEGF Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Anti-VEGF Product Type
Table 9. List of Global Tier 1 Anti-VEGF Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-VEGF Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Anti-VEGF Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Anti-VEGF Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Anti-VEGF Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Anti-VEGF Sales (K Units), 2019-2024
Table 15. By Type - Global Anti-VEGF Sales (K Units), 2025-2030
Table 16. By Application ? Global Anti-VEGF Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Anti-VEGF Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Anti-VEGF Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Anti-VEGF Sales (K Units), 2019-2024
Table 20. By Application - Global Anti-VEGF Sales (K Units), 2025-2030
Table 21. By Region ? Global Anti-VEGF Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Anti-VEGF Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Anti-VEGF Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Anti-VEGF Sales (K Units), 2019-2024
Table 25. By Region - Global Anti-VEGF Sales (K Units), 2025-2030
Table 26. By Country - North America Anti-VEGF Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Anti-VEGF Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Anti-VEGF Sales, (K Units), 2019-2024
Table 29. By Country - North America Anti-VEGF Sales, (K Units), 2025-2030
Table 30. By Country - Europe Anti-VEGF Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Anti-VEGF Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Anti-VEGF Sales, (K Units), 2019-2024
Table 33. By Country - Europe Anti-VEGF Sales, (K Units), 2025-2030
Table 34. By Region - Asia Anti-VEGF Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Anti-VEGF Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Anti-VEGF Sales, (K Units), 2019-2024
Table 37. By Region - Asia Anti-VEGF Sales, (K Units), 2025-2030
Table 38. By Country - South America Anti-VEGF Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Anti-VEGF Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Anti-VEGF Sales, (K Units), 2019-2024
Table 41. By Country - South America Anti-VEGF Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Anti-VEGF Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Anti-VEGF Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Anti-VEGF Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Anti-VEGF Sales, (K Units), 2025-2030
Table 46. Amgen Inc. Company Summary
Table 47. Amgen Inc. Anti-VEGF Product Offerings
Table 48. Amgen Inc. Anti-VEGF Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Amgen Inc. Key News & Latest Developments
Table 50. F. Hoffmann-La Roche Ltd. Company Summary
Table 51. F. Hoffmann-La Roche Ltd. Anti-VEGF Product Offerings
Table 52. F. Hoffmann-La Roche Ltd. Anti-VEGF Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 54. Pfizer, Inc. Company Summary
Table 55. Pfizer, Inc. Anti-VEGF Product Offerings
Table 56. Pfizer, Inc. Anti-VEGF Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Pfizer, Inc. Key News & Latest Developments
Table 58. Xbrane Biopharma AB Company Summary
Table 59. Xbrane Biopharma AB Anti-VEGF Product Offerings
Table 60. Xbrane Biopharma AB Anti-VEGF Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Xbrane Biopharma AB Key News & Latest Developments
Table 62. Allergan, Bayer AG Company Summary
Table 63. Allergan, Bayer AG Anti-VEGF Product Offerings
Table 64. Allergan, Bayer AG Anti-VEGF Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Allergan, Bayer AG Key News & Latest Developments
Table 66. Regeneron Pharmaceuticals Inc. Company Summary
Table 67. Regeneron Pharmaceuticals Inc. Anti-VEGF Product Offerings
Table 68. Regeneron Pharmaceuticals Inc. Anti-VEGF Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Regeneron Pharmaceuticals Inc. Key News & Latest Developments
Table 70. Viatris Inc. (Mylan) Company Summary
Table 71. Viatris Inc. (Mylan) Anti-VEGF Product Offerings
Table 72. Viatris Inc. (Mylan) Anti-VEGF Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Viatris Inc. (Mylan) Key News & Latest Developments
Table 74. Anti-VEGF Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 75. Global Anti-VEGF Capacity Market Share of Key Manufacturers, 2022-2024
Table 76. Global Anti-VEGF Production by Region, 2019-2024 (K Units)
Table 77. Global Anti-VEGF Production by Region, 2025-2030 (K Units)
Table 78. Anti-VEGF Market Opportunities & Trends in Global Market
Table 79. Anti-VEGF Market Drivers in Global Market
Table 80. Anti-VEGF Market Restraints in Global Market
Table 81. Anti-VEGF Raw Materials
Table 82. Anti-VEGF Raw Materials Suppliers in Global Market
Table 83. Typical Anti-VEGF Downstream
Table 84. Anti-VEGF Downstream Clients in Global Market
Table 85. Anti-VEGF Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-VEGF Segment by Type in 2023
Figure 2. Anti-VEGF Segment by Application in 2023
Figure 3. Global Anti-VEGF Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Anti-VEGF Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Anti-VEGF Revenue, 2019-2030 (US$, Mn)
Figure 7. Anti-VEGF Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-VEGF Revenue in 2023
Figure 9. By Type - Global Anti-VEGF Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Anti-VEGF Revenue Market Share, 2019-2030
Figure 11. By Type - Global Anti-VEGF Sales Market Share, 2019-2030
Figure 12. By Type - Global Anti-VEGF Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Anti-VEGF Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Anti-VEGF Revenue Market Share, 2019-2030
Figure 15. By Application - Global Anti-VEGF Sales Market Share, 2019-2030
Figure 16. By Application - Global Anti-VEGF Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Anti-VEGF Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Anti-VEGF Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Anti-VEGF Revenue Market Share, 2019-2030
Figure 20. By Region - Global Anti-VEGF Sales Market Share, 2019-2030
Figure 21. By Country - North America Anti-VEGF Revenue Market Share, 2019-2030
Figure 22. By Country - North America Anti-VEGF Sales Market Share, 2019-2030
Figure 23. US Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Anti-VEGF Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Anti-VEGF Sales Market Share, 2019-2030
Figure 28. Germany Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 29. France Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Anti-VEGF Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Anti-VEGF Sales Market Share, 2019-2030
Figure 37. China Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 41. India Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Anti-VEGF Revenue Market Share, 2019-2030
Figure 43. By Country - South America Anti-VEGF Sales Market Share, 2019-2030
Figure 44. Brazil Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Anti-VEGF Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Anti-VEGF Sales Market Share, 2019-2030
Figure 48. Turkey Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Anti-VEGF Revenue, (US$, Mn), 2019-2030
Figure 52. Global Anti-VEGF Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Anti-VEGF by Region, 2023 VS 2030
Figure 54. Anti-VEGF Industry Value Chain
Figure 55. Marketing Channels
